Weapon or Armor? Unpacking the Paradox of Narcissism and Self-Reported Mental Health Through a Three-Level Meta-Analysis.

J PersDec 22, 2025 (epub)
Clinical ResearchPsychiatryOpen access

Rongxia Hou, Shuqin Li, Joshua D Miller et al.

✦ AI-curated · Sources linked

In 30 seconds

This three-level meta-analysis examined associations between dimensions of narcissism and mental health, particularly internalizing psychopathology. It included 229 empirical studies (N = 185,137; k = 735 effect sizes), with findings primarily reflecting self-reported associations. Grandiose narcissism was associated with better positive mental health (r = 0.19, p < 0.001) and was not significantly associated with negative mental health (r = 0.02, p = 0.26). Vulnerable narcissism showed the opposite pattern: lower positive mental health and higher negative mental health. Age, measurement instruments, and construct specificity moderated associations.

Key findings

  • Grandiose narcissism was positively associated with positive mental health (r = 0.19, p < 0.001).
  • Grandiose narcissism had no significant association with negative mental health (r = 0.02, p = 0.26).
  • Vulnerable narcissism was negatively associated with positive mental health (r = -0.25, p < 0.001) and positively associated with negative mental health (r = 0.39, p < 0.001).
  • Age, measurement instruments, and construct specificity were significant moderators.

Why it matters

The findings indicate that narcissism is not uniformly related to mental health: associations differ by dimension and by whether mental health is positive or negative. This distinction may help clinicians and researchers avoid treating narcissism as a single construct when interpreting psychological correlates. Because most included studies used self-report measures, the results chiefly describe self-reported associations.

What to keep in mind

Most studies relied on self-report measures, so the findings primarily reflect self-reported associations.

Source

Published in J Pers. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.